PacBio to Participate in the TD Cowen 46th Annual Health Care Conference 

Rhea-AI Summary

PacBio (NASDAQ: PACB) management will participate in a fireside chat at TD Cowen's 46th Annual Health Care Conference on March 2, 2026 at 2:30 PM ET in Boston.

A live webcast will be available on the company's investor site and a replay will be accessible for at least 30 days, according to PacBio.

Key Figures

Conference edition: 46th annual Conference date: March 2, 2026 Event time: 2:30 PM ET +1 more

4 metrics

Conference edition 46th annual TD Cowen Health Care Conference

Conference date March 2, 2026 TD Cowen 46th Annual Health Care Conference

Event time 2:30 PM ET Scheduled fireside chat time

Webcast replay period 30 days Replay availability following the event

Market Reality Check

Price: $1.63 Vol: Volume 11,687,965 is 1.42...

normal vol

$1.63 Last Close

Volume Volume 11,687,965 is 1.42x the 20-day average. normal

Technical Price 1.58 is trading below the 200-day MA at 1.61.

Peers on Argus

PACB showed a -7.6% move while several peers in its sector context (e.g., DCTH, ...

1 Up

PACB showed a -7.6% move while several peers in its sector context (e.g., DCTH, RXST, SENS, SRDX, CTKB) had positive price changes, and only one peer (BFLY) appeared in the momentum scanner, also up. This points to stock‑specific dynamics rather than a broad sector move.

Common Catalyst CTKB also announced participation in the TD Cowen 46th Annual Health Care Conference, suggesting a shared conference-related news theme but differing price reactions.

Historical Context

5 past events · Latest: Feb 12 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 12	Earnings results	Neutral	+0.0%	Reported Q4 and full‑year 2025 revenue growth with improved non‑GAAP margins.
Feb 12	Partnership news	Positive	+0.0%	Joined iHope initiative as first long‑read sequencing partner for rare diseases.
Feb 02	Asset sale	Positive	-8.8%	Completed sale of short‑read assets to Illumina, receiving $48.1M net cash.
Jan 27	Earnings date notice	Neutral	+2.0%	Announced date and access details for Q4 and full‑year 2025 results call.
Jan 12	Collaboration plans	Positive	+3.6%	Planned collaboration using HiFi long‑read sequencing for ultra‑rare genetic diseases.

Pattern Detected

Recent strategic and partnership announcements have sometimes seen muted or even negative next-day moves despite constructive narratives.

Recent Company History

Over the last few months, PACB reported Q4 and full‑year 2025 results on Feb 12, 2026, showing revenue growth and improved non‑GAAP margins but large GAAP losses. It completed the sale of short‑read sequencing assets to Illumina, adding about $48.1M in net cash and sharpening focus on long‑read sequencing. Partnerships, including the iHope initiative and a rare‑disease collaboration with n‑Lorem and EspeRare, highlight emphasis on long‑read applications. Today’s conference participation fits into this pattern of ongoing outreach and strategic positioning updates.

Market Pulse Summary

This announcement highlights PACB’s participation in a TD Cowen conference, with a fireside chat on ...

Analysis

This announcement highlights PACB’s participation in a TD Cowen conference, with a fireside chat on March 2, 2026 at 2:30 PM ET and a webcast replay available for at least 30 days. In recent months the company has reported mixed financial results, executed a short‑read asset sale, and advanced collaborations in rare‑disease genomics. Investors tracking this disclosure may focus on commentary from the event in the context of those prior strategic and financial updates.

AI-generated analysis. Not financial advice.

MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at TD Cowen's 46th Annual Health Care Conference on Monday, March 2, 2026, at 2:30 PM ET in Boston, MA.

A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event.

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.

Contacts

Investors:
ir@pacb.com

Media:
pr@pacb.com

FAQ

When will PacBio (PACB) present at the TD Cowen 46th Annual Health Care Conference?

PacBio will present on March 2, 2026 at 2:30 PM ET in Boston. According to PacBio, management will join a scheduled fireside chat and webcast for investors and analysts.

How can investors watch PacBio's (PACB) TD Cowen conference presentation?

Investors can watch via a live webcast on the company's investor site. According to PacBio, the webcast link is available at investor.pacificbiosciences.com and will stream in real time.

Will PacBio (PACB) make a replay of the TD Cowen presentation available?

Yes. A replay will be available for at least 30 days after the event. According to PacBio, the replay will remain accessible on the investor site for post-event viewing.

What topics will PacBio (PACB) management likely discuss at the March 2, 2026 fireside chat?

The session will cover company updates and strategy in sequencing technology, aimed at investors. According to PacBio, management will outline recent developments and answer audience questions during the fireside chat.

Where is TD Cowen's 46th Annual Health Care Conference taking place for PacBio's presentation?

The conference session is scheduled in Boston, MA on March 2, 2026. According to PacBio, the fireside chat will be held as part of the TD Cowen conference agenda in Boston.

Is PacBio's (PACB) conference webcast free to access for retail investors?

Yes, the live webcast is publicly accessible via the company's investor website. According to PacBio, investors can view the webcast without subscription on investor.pacificbiosciences.com.